MedTrace Logo

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

NCT04613375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1821

Last updated 2025-06-11

Study results available
· View outcomes & findings →

Summary

Low interventional, prospective, multicentre, hospital-based study involving adults 60 years of age and older hospitalised with CAP at participating sites.

Conditions

  • Community Acquired Pneumonia (CAP)

Interventions

DIAGNOSTIC_TEST

Urine sample collection

Serotype specific UAD (urinary antigen detection) test

DIAGNOSTIC_TEST

Saliva collection

Streptococcus pneumonia identification in saliva samples by culture or PCR / RSV identification in saliva samples by PCR

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-12
Primary Completion
2023-10-25
Completion
2024-03-24

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04613375 on ClinicalTrials.gov